Cerenome (CNSY) Revenue (2011 - 2026)
Cerenome (CNSY) posted Revenue of $411,000 for Q2 2026, down 70.4% from $1.39 million a year earlier and down 60.0% from the prior quarter.
Powered by 
Analysis
Cerenome (CNSY) Revenue (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Cerenome was $4.2 million, down 21.0% year-over-year; for FY2025, it was $5.21 million, down 10.5% from FY2024.
- Annual Revenue shows a three-year compound annual growth rate of 185.5% (FY2022 to FY2025).
- In prior years, Cerenome's Revenue was $5.82 million in FY2024 (+18.5%), $4.91 million in FY2023 and $224,000 in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Revenue since Q4 2022.
- On a year-over-year basis, Revenue has declined in each of the last four quarters, with an average decline of 21.0% over the last eight quarters.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2023, with growth of 769.5%; the weakest was Q2 2026, with a decline of 70.4%.
- According to Business Quant data, Revenue for the three prior quarters was $1.03 million (Q1 2026), $1.37 million (Q4 2025) and $1.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Cerenome | 13.67 Mn | -33.51 Mn | - | 411,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 411,000.00 |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 506,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Mar 31, 2019 | 703,000.00 |
| Dec 31, 2018 | 1.42 Mn |
| Sep 30, 2018 | 858,000.00 |
| Jun 30, 2018 | 660,000.00 |
API Access
Cerenome Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CNSY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CNSY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CNSY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();